HEMOCHRON SIGNATURE ELITE INTERNATIONAL ELITE-INT

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed from a distributor,health profession report with the FDA on 2018-10-22 for HEMOCHRON SIGNATURE ELITE INTERNATIONAL ELITE-INT manufactured by Accriva Diagnostics.

Event Text Entries

[126246717] This mdr references accriva diagnostics' complaint number (b)(4) for the hemochron signature elite international instrument, serial number (b)(4). Accriva diagnostics' complaint number (b)(4) referenced the child case capturing the disposable hemochron jr. Act-lr device (lot number j7jlr194) that was used during the procedure. Method: testing of actual/suspected device. Dhr review showed no ncs, capa, or a relevant history of repair. Results: no device problem found. The instrument was tested to heparin sensitivty procedure qc-188 using 2 lots of act-lr cuvettes and side by side with 3 other control instruments. The device performed within specifications. Conclusion: no problem detected. This mdr serves as the initial and final report for the hemochron signature elite and act-lr microcoagulation system, instrument serial number (b)(4), lot j7jlr194. The complaint was not confirmed.
Patient Sequence No: 1, Text Type: N, H10


[126246718] Healthcare professional working in a hospital in (b)(6) reported that two hemochron signature elite and act low-range assay systems reported inconsistent act results when the meters were run side-to-side during a pci and stent placement procedure. The patient was receiving intermittent doses of intravenous heparin with a target act range of 300-350 seconds. The same lot number of hemochron jr act-lr cuvettes (j7jlr194) was used on both meters throughout the procedure. One blood sample generated a pair of act results that differed significantly from one another. The act result assayed on the elite named in this complaint ((b)(4)) was 254 seconds, which was lower than the target act. The act result reported on the second elite ((b)(4)) was 321 seconds, which was an expected result. The act result of 321 seconds was used for patient management. No bleeding, thrombosis or other medical complications were reported. Both hemochron signature elite instruments passed electronic qc before the procedure. Act-lr readings with liquid qc (normal and abnormal levels) were within their acceptable ranges when run on both instruments. The distributor asked the customer to return the device for evaluation, however, the customer declined to do so as of (b)(6) 2018, when accriva closed the initial complaint. The complaint case was reopened on (b)(6) 2018 when the customer decided to return the instrument to accriva for evaluation because of recurrent instances of reporting inconsistent act results.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report Number2250033-2018-00024
MDR Report Key7993153
Report SourceDISTRIBUTOR,HEALTH PROFESSION
Date Received2018-10-22
Date of Report2018-09-26
Date of Event2018-03-09
Date Mfgr Received2018-09-26
Device Manufacturer Date2015-03-20
Date Added to Maude2018-10-22
Event Key0
Report Source CodeManufacturer report
Manufacturer LinkY
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationBIOMEDICAL ENGINEER
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Manufacturer ContactJON MCDERMED
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal92121
Manufacturer Phone8582632490
Manufacturer G1ACCRIVA DIAGNOSTICS
Manufacturer Street6260 SEQUENCE DRIVE
Manufacturer CitySAN DIEGO CA 92121
Manufacturer CountryUS
Manufacturer Postal Code92121
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameHEMOCHRON SIGNATURE ELITE INTERNATIONAL
Generic NameSYSTEM, MULTIPURPOSE FOR IN VITRO COAGULATION STUDIES
Product CodeJPA
Date Received2018-10-22
Returned To Mfg2018-10-05
Model NumberELITE-INT
Catalog NumberELITE-INT
OperatorHEALTH PROFESSIONAL
Device AvailabilityR
Device Eval'ed by MfgrY
Device Sequence No1
Device Event Key0
ManufacturerACCRIVA DIAGNOSTICS
Manufacturer Address6260 SEQUENCE DRIVE SAN DIEGO CA 92121 US 92121


Patients

Patient NumberTreatmentOutcomeDate
10 2018-10-22

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.